27th Annual
San Diego Heart Failure Symposium

Advances in the Recognition & Treatment of Heart Failure
July 9 & 10, 2021

If you have already registered, login to access the virtual event home page, symposium syllabus, speaker slides and CME surveys (valid registration email address required).


CME Certificates will be issued digitally after Speaker Evaluations and Overall Surveys are completed. Surveys are accessible after logging in with the email address you submitted during registration. Surveys will be available online starting the day of the symposium. You must complete the process by August 2, 2021 in order to receive your certificate. Certificates will be available online until December 31st and are printable directly from the website.


The AAFP has reviewed 27th Annual San Diego Heart Failure Symposium and deemed it acceptable for up to 10.00 Online Only, Live AAFP Prescribed credit. Term of Approval is from 07/09/2021 to 07/10/2021. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Please complete this 5 question pre-test prior to the presentation:

In order to receive your CME certificate Session III on Friday, please complete the brief post-test & evaluation here:


Officially endorsed by the Heart Failure Society of America. The opinions presented in this educational activity do not necessarily reflect the opinions or recommendations of the HFSA.


The 27th Annual San Diego Heart Failure Symposium provides an excellent opportunity to learn about best practices and new advances in the management of heart failure from a faculty that includes world renowned experts in the field. As the meeting will be virtual, registrants will be able to attend the meeting and discussions as they occur and also to access them online for several additional weeks. As in the past, we offer a series of didactic lectures and panel discussions that will include opportunities for audience participation in the Q and A sessions. We have added a special case based learning session to start the Symposium on Friday morning. There will also be several Product Theater presentations for more in-depth discussion of specific approaches to treatment. The talks included in the Symposium cover a broad array of relevant topics ranging from management of risk factors, treatment of patients during and following a heart failure hospitalization, overview of new drugs, role of devices, update on COVID-19 effects on the heart, treatment of arrhythmias and disparities in health care.

This year, the 7th Annual Stanley Lloyd M.D. lecture will be presented by Dr. Carolyn Lam, who is a Professor at the National University Hospital in Singapore. Dr. Lam will provide her insights into the pathophysiology and treatment of patients with HFpEF, an area where she has been a world leader in finding new treatments. This years ‘virtual’ meeting provides an excellent opportunity to keep up with the exciting changes that have been taking place in heart failure management over the year. I’m sure that it is one that you will not want to miss.


The target audience for this activity includes cardiologists, internists, primary care physicians, nurses and allied healthcare professionals.


At the conclusion of this activity, participants should be able to:

  1. Summarize current and emerging treatments that can be used to prevent heart failure.
  2. Describe new guideline updates and summarize practical information to help in the implementation of recommended drug therapies for treating heart failure.
  3. Provide an overview of which patients should be considered for individual therapies.
  4. Summarize information about the efficacy and safety of device therapies for detecting and treating patients with heart failure.
  5. Describe the cardiovascular complications of COVID-19 infection and the impact of infection on the management of patients with heart failure.
  6. Describe existing disparities in healthcare, their impact on outcomes, how specific populations including minorities, women and the elderly respond to various treatment of heart failure and proposed strategies for overcoming health disparities.


Heart failure (HF) is common, affecting nearly 5 million Americans. It is also one of the few cardiovascular disorders for which prevalence figures are increasing. An estimated 670,000 new cases of heart failure are diagnosed each year and this condition is a major cause of morbidity and mortality (80% of men and 70% of women less than 65 years of age who have HF will die within 8 years). Overall, HF is the number one cause of hospitalizations of the elderly in the U.S.

Knowledge about HF is accumulating rapidly. To help individual clinicians synthesize new information and integrate new approaches into effective strategies of care for patients with this syndrome. The Symposium will provide a comprehensive overview of diagnostic approaches, current evidence-based therapies and treatment strategies as well as emerging approaches for treatment.